Literature DB >> 31389887

Is Spinal Anesthesia Safer than General Anesthesia for Patients Undergoing Revision THA? Analysis of the ACS-NSQIP Database.

Jacob M Wilson1, Kevin X Farley1, Thomas L Bradbury1, George N Guild1.   

Abstract

BACKGROUND: The incidence of revision THA continues to increase and there is a need to identify risk factors contributing to postoperative complications. Anesthesia type has been shown to be associated with complication rates in patients who undergo primary THA, but it is not clear whether the same is true among patients undergoing revision THA. QUESTIONS/PURPOSES: (1) After controlling for confounding variables, in the setting of a large-database analysis, is spinal anesthesia associated with a lower risk of death, readmission, reoperation, postoperative transfusion, thromboembolic events, surgical site infection (SSI), and re-intubation among patients undergoing revision THA?
METHODS: The American College of Surgeons-National Surgical Quality Improvement (ACS-NSQIP) database was queried for patients undergoing aseptic, revision THA with either spinal or general anesthesia. Coarsened exact matching was used to match patients based on several baseline characteristics, including age, sex, body mass index, surgery type (Current Procedural Terminology code), and the modified Frailty Index score. Coarsened exact matching is a statistical method of exact matching that matches on chosen characteristics, in which continuous variables may be temporarily coarsened (such as, into discrete categorical variables) to facilitate matching. This method is an alternate to and requires less estimation than traditional propensity score matching. Then, using a model controlling for baseline patient characteristics and operative time, we performed multivariate logistic and linear regression analyses of matched cohorts to examine differences in mortality, readmission, reoperation, thromboembolic events, transfusion, SSI, and re-intubation.
RESULTS: After statistical matching and controlling for baseline demographic variables, surgery type (one- or two-component revision), surgical time and modified Frailty Index we found that patients receiving general anesthesia had higher odds of mortality (OR 3.72 [95% CI 1.31 to 10.50]; p = 0.013), readmission (OR 1.49 [95% CI 1.24 to 1.80]; p < 0.001), reoperation (OR 1.40 [95% CI 1.13 to 1.73]; p = 0.002), thromboembolic events (OR 2.57 [95% CI 1.37 to 4.84]; p = 0.003), SSI (OR 1.32 [95% CI 1.01 to 1.72]; p = 0.046), postoperative transfusion (OR 1.57 [95%CI 1.39 to 1.78]; p < 0.001) and unplanned intubation or failure to wean off intubation (OR 5.95 [95% CI 1.43 to 24.72]; p = 0.014).
CONCLUSIONS: In patients undergoing revision THA, spinal anesthesia is associated with a decreased risk of several complications. The current investigation suggests that, when practical (such as when long surgical times or changes to the surgical plan are not anticipated), spinal anesthesia should be considered for use during revision THA. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2020        PMID: 31389887      PMCID: PMC7000063          DOI: 10.1097/CORR.0000000000000887

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


  46 in total

Review 1.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

Review 2.  Regional anesthesia in hip surgery.

Authors:  Pier Francesco Indelli; Stuart A Grant; Karen Nielsen; Thomas Parker Vail
Journal:  Clin Orthop Relat Res       Date:  2005-12       Impact factor: 4.176

3.  Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion.

Authors:  P Juelsgaard; U T Larsen; J V Sørensen; F Madsen; K Søballe
Journal:  Reg Anesth Pain Med       Date:  2001 Mar-Apr       Impact factor: 6.288

4.  Modified Frailty Index Is an Effective Risk Assessment Tool in Primary Total Hip Arthroplasty.

Authors:  Jaime L Bellamy; Robert P Runner; CatPhuong Cathy L Vu; Mara L Schenker; Thomas L Bradbury; James R Roberson
Journal:  J Arthroplasty       Date:  2017-05-04       Impact factor: 4.757

5.  Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population.

Authors:  J N Katz; E Losina; J Barrett; C B Phillips; N N Mahomed; R A Lew; E Guadagnoli; W H Harris; R Poss; J A Baron
Journal:  J Bone Joint Surg Am       Date:  2001-11       Impact factor: 5.284

6.  High-volume surgeons in regard to reductions in operating time, blood loss, and postoperative complications for total hip arthroplasty.

Authors:  Hideo Yasunaga; Kazuaki Tsuchiya; Yutaka Matsuyama; Kazuhiko Ohe
Journal:  J Orthop Sci       Date:  2009-02-13       Impact factor: 1.601

7.  Thromboembolism after total hip replacement: role of epidural and general anesthesia.

Authors:  J Modig; T Borg; G Karlström; E Maripuu; B Sahlstedt
Journal:  Anesth Analg       Date:  1983-02       Impact factor: 5.108

8.  Prevalence of Total Hip and Knee Replacement in the United States.

Authors:  Hilal Maradit Kremers; Dirk R Larson; Cynthia S Crowson; Walter K Kremers; Raynard E Washington; Claudia A Steiner; William A Jiranek; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2015-09-02       Impact factor: 5.284

9.  Association between hospital and surgeon procedure volume and the outcomes of total knee replacement.

Authors:  Jeffrey N Katz; Jane Barrett; Nizar N Mahomed; John A Baron; R John Wright; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2004-09       Impact factor: 5.284

10.  Effects of anaesthetic technique on deep vein thrombosis. A comparison of subarachnoid and general anaesthesia.

Authors:  P J McKenzie; H Y Wishart; I Gray; G Smith
Journal:  Br J Anaesth       Date:  1985-09       Impact factor: 9.166

View more
  7 in total

1.  Short-term mortality after primary and revision total joint arthroplasty: a single-center analysis of 103,560 patients.

Authors:  Felix Prange; Alina Seifert; Pongsiri Piakong; Thorsten Gehrke; Dario Guttowski; Sophia-Marlene Busch; Jochen Salber; Mustafa Citak
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-03       Impact factor: 3.067

2.  Outcomes following outpatient anterior cervical discectomy and fusion for the treatment of myelopathy.

Authors:  Ryan Lee; Danny Lee; Uchechi Iweala; Pradip Ramamurti; Jeffrey H Weinreb; Joseph R O'Brien
Journal:  J Clin Orthop Trauma       Date:  2020-08-09

3.  Complications following regional anesthesia versus general anesthesia for the treatment of distal radius fractures.

Authors:  Ryan Lee; Danny Lee; Pradip Ramamurti; Safa Fassihi; Jessica H Heyer; Monica Stadecker; Michael Webber; Alice Hughes; Rajeev Pandarinath
Journal:  Eur J Trauma Emerg Surg       Date:  2021-05-29       Impact factor: 2.374

4.  CORR Insights®: Is Spinal Anesthesia Safer than General Anesthesia for Patients Undergoing Revision THA? Analysis of the ACS-NSQIP Database.

Authors:  Charles N Cornell
Journal:  Clin Orthop Relat Res       Date:  2020-01       Impact factor: 4.755

5.  Prevention of early complications following total hip replacement.

Authors:  Andreas Fontalis; Daniel J Berry; Andrew Shimmin; Pablo A Slullitel; Martin A Buttaro; Cao Li; Henrik Malchau; Fares S Haddad
Journal:  SICOT J       Date:  2021-11-30

6.  What Factors Predict Adverse Discharge Disposition in Patients Older Than 60 Years Undergoing Lower-extremity Surgery? The Adverse Discharge in Older Patients after Lower-extremity Surgery (ADELES) Risk Score.

Authors:  Maximilian S Schaefer; Maximilian Hammer; Katharina Platzbecker; Peter Santer; Stephanie D Grabitz; Kadhiresan R Murugappan; Tim Houle; Sheila Barnett; Edward K Rodriguez; Matthias Eikermann
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

7.  Delivering Essential Surgical Care for Lower-limb Musculoskeletal disorders in the Low-Resource Setting.

Authors:  Deeptiman James; Faye M Evans; Ekta Rai; Nobhojit Roy
Journal:  World J Surg       Date:  2021-06-29       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.